RECURRENT PROSTATE CARCINOMA
Clinical trials for RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart risk showdown: which prostate cancer drug is safer?
Disease control Recruiting nowThis study compares two hormone therapy combinations (leuprolide or relugolix plus abiraterone acetate) in men with advanced prostate cancer who are also getting radiation. The goal is to see which combination causes less harm to the heart, since these treatments can raise blood …
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced cancers with DNA repair flaws: PARP inhibitor trial opens
Disease control Recruiting nowThis study tests the drug talazoparib in adults with advanced solid tumors (like breast, prostate, ovarian, pancreatic, or stomach cancer) that have certain gene changes affecting DNA repair. The drug blocks a protein called PARP, which cancer cells need to fix their DNA, potenti…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New study tests fasting and Weight-Loss drugs to shield hearts during prostate cancer treatment
Disease control Recruiting nowThis study looks at whether time-restricted eating (intermittent fasting) or GLP-1 medications (semaglutide and tirzepatide) can better protect the heart and metabolism of prostate cancer patients on hormone therapy compared to a standard heart-healthy diet. About 60 men aged 30-…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Scientists hunt for clues to cancer resistance in tissue samples
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 1,500 people with prostate or bladder cancer that has returned or spread. Researchers will analyze these samples to find new biomarkers and understand why some cancers stop responding to treatment. The goal is to improve future th…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New imaging agent may help surgeons spot hidden prostate cancer
Knowledge-focused Recruiting nowThis early study tests a radioactive imaging agent called 99mTc-PSMA-I&S in 30 men with prostate cancer who are scheduled for lymph node removal surgery. The goal is to see how the agent spreads in the body and whether it can help surgeons detect cancer that has spread to lymph n…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC